Skip to main content
. 2013 Oct 10;4:2591. doi: 10.1038/ncomms3591

Figure 1. Schematics of DPN and lipid molecule structures.

Figure 1

(a) Scheme of the writing process and (be) the phospholipids used in our study: (b) the main constituent of the phospholipid ink used as carrier, DOPC and three functional admixtures (c) the fluorescently labelled Liss Rhod PE, (d) the biotinylated Biotinyl Cap PE and (e) the negatively charged DOPA.